Title : Dual Targeting of Epidermal Growth Factor Receptor and HER3 by MEHD7945A as Monotherapy or in Combination with Cisplatin Partially Overcomes Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma Cell Lines.

Pub. Date : 2017 Sep

PMID : 28910149






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Dual Targeting of Epidermal Growth Factor Receptor and HER3 by MEHD7945A as Monotherapy or in Combination with Cisplatin Partially Overcomes Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma Cell Lines. Cisplatin epidermal growth factor receptor Homo sapiens